Emergency Use Authorization for Vaccines to Prevent COVID-19

On 22 February 2021 the FDA issued additional guidance for industry.

FDA is issuing this guidance to provide sponsors of requests for Emergency Use Authorization (EUA) for COVID-19 vaccines with recommendations regarding the data and information needed to support the issuance of an EUA under section 564 of the FD&C Act (21 U.S.C. 360bbb-3) for an investigational vaccine to prevent COVID-19 for the duration of the COVID-19 public health emergency.

Read more online 
Copyright Widler & Schiemann AG 2020. All Rights Reserved. /